Atenção: Todas as denúncias são sigilosas e sua identidade será preservada.
Os campos nome e e-mail são de preenchimento opcional
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.contributor | Universidade Estadual Paulista (Unesp) | - |
Autor(es): dc.contributor | Maternity School of Rio de Janeiro Federal University | - |
Autor(es): dc.contributor | University of Buenos Aires | - |
Autor(es): dc.contributor | University of Caldas | - |
Autor(es): dc.contributor | Universidade Federal de São Paulo (UNIFESP) | - |
Autor(es): dc.contributor | Harvard Medical School | - |
Autor(es): dc.creator | Maestá, Izildinha [UNESP] | - |
Autor(es): dc.creator | De Freitas Segalla Moreira, Marjory [UNESP] | - |
Autor(es): dc.creator | Rezende-Filho, Jorge | - |
Autor(es): dc.creator | Bianconi, Maria Inés | - |
Autor(es): dc.creator | Jankilevich, Gustavo | - |
Autor(es): dc.creator | Otero, Silvina | - |
Autor(es): dc.creator | Correa Ramirez, Luz Angela [UNESP] | - |
Autor(es): dc.creator | Sun, Sue Yazaki | - |
Autor(es): dc.creator | Elias, Kevin | - |
Autor(es): dc.creator | Horowitz, Neil | - |
Autor(es): dc.creator | Braga, Antonio | - |
Autor(es): dc.creator | Berkowitz, Ross | - |
Data de aceite: dc.date.accessioned | 2022-02-22T00:34:29Z | - |
Data de disponibilização: dc.date.available | 2022-02-22T00:34:29Z | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2020-12-11 | - |
Data de envio: dc.date.issued | 2020-09-01 | - |
Fonte completa do material: dc.identifier | http://dx.doi.org/10.1136/ijgc-2020-001237 | - |
Fonte completa do material: dc.identifier | http://hdl.handle.net/11449/201777 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/11449/201777 | - |
Descrição: dc.description | Background South America has a higher incidence of gestational trophoblastic disease than North America or Europe, but whether this impacts chemotherapy outcomes is unclear. The purpose of this study was to evaluate outcomes among women with high-risk gestational trophoblastic neoplasia (GTN) treated at trophoblastic disease centers in developing South American countries. Methods This retrospective cohort study included patients with high-risk GTN treated in three trophoblastic disease centers in South America (Botucatu and Rio de Janeiro, Brazil, and Buenos Aires, Argentina) from January 1990 to December 2014. Data evaluated included demographics, clinical presentation, FIGO stage, WHO prognostic risk score, and treatment-related information. The primary treatment outcome was complete sustained remission by 18 months following completion of therapy or death. Results Among 1264 patients with GTN, 191 (15.1%) patients had high-risk GTN and 147 were eligible for the study. Complete sustained remission was ultimately achieved in 87.1% of cases overall, including 68.4% of ultra high-risk GTN (score ≥12). Early death (within 4 weeks of initiating therapy) was significantly associated with ultra high-risk GTN, occurring in 13.8% of these patients (p=0.003). By Cox's proportional hazards regression, factors most strongly related to death were non-molar antecedent pregnancy (RR 4.35, 95% CI 1.71 to 11.05), presence of liver, brain, or kidney metastases (RR 4.99, 95% CI 1.96 to 12.71), FIGO stage (RR 3.14, 95% CI 1.52 to 6.53), and an ultra-high-risk prognostic risk score (RR 7.86, 95% CI 2.99 to 20.71). Median follow-up after completion of chemotherapy was 4 years. Among patients followed to that timepoint, the probability of survival was 90% for patients with high-risk GTN (score 7-11) and 60% for patients with ultra-high-risk GTN (score ≥12). Conclusion Trophoblastic disease centers in developing South American countries have achieved high remission rates in high-risk GTN, but early deaths remain an important problem, particularly in ultra-high-risk GTN. | - |
Descrição: dc.description | Botucatu Trophoblastic Disease Center Botucatu Medical School Sao Paulo State University Julio de Mesquita Filho-UNESP | - |
Descrição: dc.description | Rio de Janeiro Trophoblastic Disease Center Maternity School of Rio de Janeiro Federal University | - |
Descrição: dc.description | Carlos G Durand Hospital Trophoblastic Disease Center Faculty of Medicine University of Buenos Aires | - |
Descrição: dc.description | Botucatu Medical School Sao Paulo State University Julio de Mesquita Filho-UNESP | - |
Descrição: dc.description | University of Caldas | - |
Descrição: dc.description | São Paulo Hospital Trophoblastic Disease Center Escola Paulista de Medicina Universidade Federal de São Paulo | - |
Descrição: dc.description | Division of Gynecologic Oncology Department of Obstetrics Gynecology and Reproductive Biology New England Trophoblastic Disease Center Brigham and Women's Hospital Harvard Medical School | - |
Descrição: dc.description | Botucatu Trophoblastic Disease Center Botucatu Medical School Sao Paulo State University Julio de Mesquita Filho-UNESP | - |
Descrição: dc.description | Botucatu Medical School Sao Paulo State University Julio de Mesquita Filho-UNESP | - |
Formato: dc.format | 1366-1371 | - |
Idioma: dc.language | en | - |
Relação: dc.relation | International Journal of Gynecological Cancer | - |
???dc.source???: dc.source | Scopus | - |
Palavras-chave: dc.subject | gestational trophoblastic disease | - |
Palavras-chave: dc.subject | trophoblastic neoplasms | - |
Título: dc.title | Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America | - |
Tipo de arquivo: dc.type | livro digital | - |
Aparece nas coleções: | Repositório Institucional - Unesp |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: